124 related articles for article (PubMed ID: 28279340)
1. Unsweetened IgG Is Bad for Dengue Patients.
Lok SM
Cell Host Microbe; 2017 Mar; 21(3):312-314. PubMed ID: 28279340
[TBL] [Abstract][Full Text] [Related]
2. Antibody avidity following secondary dengue virus type 2 infection across a range of disease severity.
Lau L; Green AM; Balmaseda A; Harris E
J Clin Virol; 2015 Aug; 69():63-7. PubMed ID: 26209381
[TBL] [Abstract][Full Text] [Related]
3. Indices of anti-dengue immunoglobulin G subclasses in adult Mexican patients with febrile and hemorrhagic dengue in the acute phase.
Posadas-Mondragón A; Aguilar-Faisal JL; Chávez-Negrete A; Guillén-Salomón E; Alcántara-Farfán V; Luna-Rojas L; Ávila-Trejo AM; Del Carmen Pacheco-Yépez J
Microbiol Immunol; 2017 Oct; 61(10):433-441. PubMed ID: 28881485
[TBL] [Abstract][Full Text] [Related]
4. Dengue NS1-specific antibody responses: isotype distribution and serotyping in patients with Dengue fever and Dengue hemorrhagic fever.
Shu PY; Chen LK; Chang SF; Yueh YY; Chow L; Chien LJ; Chin C; Lin TH; Huang JH
J Med Virol; 2000 Oct; 62(2):224-32. PubMed ID: 11002252
[TBL] [Abstract][Full Text] [Related]
5. Higher levels of dengue-virus-specific IgG and IgA during pre-defervescence associated with primary dengue hemorrhagic fever.
Bachal R; Alagarasu K; Singh A; Salunke A; Shah P; Cecilia D
Arch Virol; 2015 Oct; 160(10):2435-43. PubMed ID: 26175069
[TBL] [Abstract][Full Text] [Related]
6. Characterization of dengue virus infections in a sample of patients suggests unique clinical, immunological, and virological profiles that impact on the diagnosis of dengue and dengue hemorrhagic fever.
Senaratne T; Wimalaratne H; Alahakoon DG; Gunawardane N; Carr J; Noordeen F
J Med Virol; 2016 Oct; 88(10):1703-10. PubMed ID: 26990973
[TBL] [Abstract][Full Text] [Related]
7. Serodiagnosis of dengue virus infection in patients presenting to a tertiary care hospital.
Neeraja M; Lakshmi V; Teja VD; Umabala P; Subbalakshmi MV
Indian J Med Microbiol; 2006 Oct; 24(4):280-2. PubMed ID: 17185847
[TBL] [Abstract][Full Text] [Related]
8. Maternal Anti-Dengue IgG Fucosylation Predicts Susceptibility to Dengue Disease in Infants.
Thulin NK; Brewer RC; Sherwood R; Bournazos S; Edwards KG; Ramadoss NS; Taubenberger JK; Memoli M; Gentles AJ; Jagannathan P; Zhang S; Libraty DH; Wang TT
Cell Rep; 2020 May; 31(6):107642. PubMed ID: 32402275
[TBL] [Abstract][Full Text] [Related]
9. Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies.
Tsai WY; Durbin A; Tsai JJ; Hsieh SC; Whitehead S; Wang WK
J Virol; 2015 Jul; 89(14):7348-62. PubMed ID: 25972550
[TBL] [Abstract][Full Text] [Related]
10. Modelling original antigenic sin in dengue viral infection.
Nikin-Beers R; Ciupe SM
Math Med Biol; 2018 Jun; 35(2):257-272. PubMed ID: 28339786
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the 2013 dengue epidemic in Myanmar with dengue virus 1 as the dominant serotype.
Ngwe Tun MM; Kyaw AK; Makki N; Muthugala R; Nabeshima T; Inoue S; Hayasaka D; Moi ML; Buerano CC; Thwe SM; Thant KZ; Morita K
Infect Genet Evol; 2016 Sep; 43():31-7. PubMed ID: 27154331
[TBL] [Abstract][Full Text] [Related]
12. [Hemorrhagic dengue fever after trip to Malaysia].
Hafner C; Koellner K; Vogt T; Landthaler M; Szeimies RM
Hautarzt; 2006 Aug; 57(8):705-7. PubMed ID: 16283129
[TBL] [Abstract][Full Text] [Related]
13. Implications of previous subclinical dengue infection but not virus load in dengue hemorrhagic fever.
Yeh WT; Chen RF; Wang L; Liu JW; Shaio MF; Yang KD
FEMS Immunol Med Microbiol; 2006 Oct; 48(1):84-90. PubMed ID: 16965355
[TBL] [Abstract][Full Text] [Related]
14. Dengue serotype-specific differences in clinical manifestation, laboratory parameters and risk of severe disease in adults, singapore.
Yung CF; Lee KS; Thein TL; Tan LK; Gan VC; Wong JGX; Lye DC; Ng LC; Leo YS
Am J Trop Med Hyg; 2015 May; 92(5):999-1005. PubMed ID: 25825386
[TBL] [Abstract][Full Text] [Related]
15. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.
Sasaki T; Setthapramote C; Kurosu T; Nishimura M; Asai A; Omokoko MD; Pipattanaboon C; Pitaksajjakul P; Limkittikul K; Subchareon A; Chaichana P; Okabayashi T; Hirai I; Leaungwutiwong P; Misaki R; Fujiyama K; Ono K; Okuno Y; Ramasoota P; Ikuta K
Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996-1997 dengue-2 outbreak in French Polynesia.
Murgue B; Roche C; Chungue E; Deparis X
J Med Virol; 2000 Apr; 60(4):432-8. PubMed ID: 10686027
[TBL] [Abstract][Full Text] [Related]
17. Impact of dengue virus infection and its control.
Igarashi A
FEMS Immunol Med Microbiol; 1997 Aug; 18(4):291-300. PubMed ID: 9348165
[TBL] [Abstract][Full Text] [Related]
18. A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. studies in 1995-1996.
Graham RR; Juffrie M; Tan R; Hayes CG; Laksono I; Ma'roef C; Erlin ; Sutaryo ; Porter KR; Halstead SB
Am J Trop Med Hyg; 1999 Sep; 61(3):412-9. PubMed ID: 10497982
[TBL] [Abstract][Full Text] [Related]
19. Incorporation of IgG Depletion in a Neutralization Assay Facilitates Differential Diagnosis of Zika and Dengue in Secondary Flavivirus Infection Cases.
Calvert AE; Boroughs KL; Laven J; Stovall JL; Luy BE; Kosoy OI; Huang CY
J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618505
[TBL] [Abstract][Full Text] [Related]
20. Dengue virus infection-enhancing activity of undiluted sera obtained from patients with secondary dengue virus infection.
Moi ML; Takasaki T; Saijo M; Kurane I
Trans R Soc Trop Med Hyg; 2013 Jan; 107(1):51-8. PubMed ID: 23296697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
